{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:17:46Z","timestamp":1758053866989,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.curtheres.2023.100694","type":"journal-article","created":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T09:47:16Z","timestamp":1674985636000},"page":"100694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation"],"prefix":"10.1016","volume":"98","author":[{"given":"David","family":"Farchadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal E.","family":"Slatkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Stambler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Matus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2023.100694_bib0001","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2147\/JPR.S160045","article-title":"Resource use and costs associated with opioid-induced constipation following total hip or total knee replacement surgery","volume":"11","author":"Wittbrodt","year":"2018","journal-title":"J Pain Res"},{"issue":"2","key":"10.1016\/j.curtheres.2023.100694_bib0002","first-page":"93","article-title":"Economic burden of opioid-induced constipation among long-term opioid users with noncancer pain","volume":"8","author":"Wan","year":"2015","journal-title":"Am Health Drug Benefits"},{"issue":"10","key":"10.1016\/j.curtheres.2023.100694_bib0003","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/nmo.12417","article-title":"Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation","volume":"26","author":"Camilleri","year":"2014","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"10.1016\/j.curtheres.2023.100694_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4637.2008.00495.x","article-title":"The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (PROBE 1)","volume":"10","author":"Bell","year":"2009","journal-title":"Pain Med"},{"issue":"3","key":"10.1016\/j.curtheres.2023.100694_bib0005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpainsymman.2004.06.013","article-title":"Constipation management in palliative care: a survey of practices in the United Kingdom","volume":"29","author":"Goodman","year":"2005","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"10.1016\/j.curtheres.2023.100694_bib0006","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/0269216308096908","article-title":"The management of constipation in palliative care: clinical practice recommendations","volume":"22","author":"Larkin","year":"2008","journal-title":"Palliat Med"},{"issue":"suppl4","key":"10.1016\/j.curtheres.2023.100694_bib0007","doi-asserted-by":"crossref","first-page":"iv111","DOI":"10.1093\/annonc\/mdy148","article-title":"Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines","volume":"29","author":"Larkin","year":"2018","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.curtheres.2023.100694_bib0008","first-page":"44","article-title":"Opioid use patterns and health care resource utilization in patients prescribed opioid therapy with and without constipation","volume":"19","author":"Iyer","year":"2010","journal-title":"Manag Care"},{"issue":"2","key":"10.1016\/j.curtheres.2023.100694_bib0009","first-page":"687","article-title":"Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy","volume":"27","author":"Fine","year":"2019","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.curtheres.2023.100694_bib0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/15360280903098440","article-title":"Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy","volume":"23","author":"Candrilli","year":"2009","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"5","key":"10.1016\/j.curtheres.2023.100694_bib0011","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s10620-018-5394-8","article-title":"Significant morbidity and mortality associated with fecal impaction in patients who present to the emergency department","volume":"64","author":"Sommers","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.curtheres.2023.100694_bib0012","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijscr.2017.11.060","article-title":"Opioid drugs and stercoral perforation of the colon: Case report and review of literature","volume":"42","author":"Poitras","year":"2018","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.curtheres.2023.100694_bib0013","article-title":"Rapid death following undiagnosed stercoral perforation in a chronic opioid user","volume":"42","author":"Heimer","year":"2019","journal-title":"Leg Med"},{"issue":"8","key":"10.1016\/j.curtheres.2023.100694_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105281","article-title":"A nation-wide study of prevalence and risk factors for fecal impaction in nursing homes","volume":"9","author":"Rey","year":"2014","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.curtheres.2023.100694_bib0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0269216312450358","article-title":"A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease","volume":"27","author":"Dhingra","year":"2013","journal-title":"Palliat Med"},{"issue":"6","key":"10.1016\/j.curtheres.2023.100694_bib0016","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/bja\/aeg275","article-title":"Constipation and its implications in the critically ill patient","volume":"91","author":"Mostafa","year":"2003","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.curtheres.2023.100694_bib0017","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/0897190017745395","article-title":"The evolving role of long-term pharmacotherapy for opioid-induced constipation in patients being treated for noncancer pain","volume":"32","author":"Bowers","year":"2019","journal-title":"J\u00a0Pharm Pract"},{"issue":"6","key":"10.1016\/j.curtheres.2023.100694_bib0018","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/AJP.0b013e31820d9b76","article-title":"Use of medications and resources for treatment of nausea, vomiting, or constipation in hospitalized patients treated with analgesics","volume":"27","author":"Suh","year":"2011","journal-title":"Clin J Pain"},{"issue":"12","key":"10.1016\/j.curtheres.2023.100694_bib0019","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-2036.2008.03689.x","article-title":"Gastrointestinal side effects in chronic opioid users: results from a population-based survey","volume":"27","author":"Cook","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.curtheres.2023.100694_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/141737","article-title":"Opioid-induced constipation: pathophysiology, clinical consequences, and management","author":"Kumar","year":"2014","journal-title":"Gastroenterol Res Pract"},{"issue":"4","key":"10.1016\/j.curtheres.2023.100694_bib0021","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1756283X15578608","article-title":"Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities","volume":"8","author":"Nelson","year":"2015","journal-title":"Therap Adv Gastroenterol"},{"issue":"8","key":"10.1016\/j.curtheres.2023.100694_bib0022","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/pme.12724","article-title":"Opioid-induced constipation among patients with chronic noncancer pain in the United States, Canada, Germany, and the United Kingdom: laxative use, response, and symptom burden over time","volume":"16","author":"Coyne","year":"2015","journal-title":"Pain Med"},{"year":"2018","author":"Relistor [package insert]","key":"10.1016\/j.curtheres.2023.100694_bib0023"},{"issue":"1","key":"10.1016\/j.curtheres.2023.100694_bib0024","first-page":"39","article-title":"Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients","volume":"7","author":"Slatkin","year":"2009","journal-title":"J Support Oncol"},{"issue":"22","key":"10.1016\/j.curtheres.2023.100694_bib0025","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1056\/NEJMoa0707377","article-title":"Methylnaltrexone for opioid-induced constipation in advanced illness","volume":"358","author":"Thomas","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.curtheres.2023.100694_bib0026","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0009-9236(96)90117-4","article-title":"Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial","volume":"59","author":"Yuan","year":"1996","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.curtheres.2023.100694_bib0027","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/jpm.2014.0362","article-title":"Fixed-dose subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: results of a randomized, placebo-controlled study and open-label extension","volume":"18","author":"Bull","year":"2015","journal-title":"J Palliat Med"},{"issue":"6","key":"10.1016\/j.curtheres.2023.100694_bib0028","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/papr.12535","article-title":"Randomized, double-blind trial of oral methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic noncancer pain","volume":"17","author":"Rauck","year":"2017","journal-title":"Pain Pract"},{"issue":"5","key":"10.1016\/j.curtheres.2023.100694_bib0029","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jpain.2010.11.008","article-title":"Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study","volume":"12","author":"Michna","year":"2011","journal-title":"J Pain"},{"key":"10.1016\/j.curtheres.2023.100694_bib0030","unstructured":"ECOG performance status. 2019. https:\/\/ecog-acrin.org\/resources\/ecog-performance-status. Accessed October 3, 2019."},{"key":"10.1016\/j.curtheres.2023.100694_bib0031","unstructured":"Study evaluating subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with advanced illness [NCT00672477]. 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00672477?view=results. Accessed April 7, 2022."},{"issue":"5","key":"10.1016\/j.curtheres.2023.100694_bib0032","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jpainsymman.2011.02.015","article-title":"Characterization of abdominal pain during methylnaltrexone treatment of opioid-induced constipation in advanced illness: a post hoc analysis of two clinical trials","volume":"42","author":"Slatkin","year":"2011","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.curtheres.2023.100694_bib0033","first-page":"160","article-title":"Increased burden of healthcare utilization and cost associated with opioid-related constipation among patients with noncancer pain","volume":"9","author":"Fernandes","year":"2016","journal-title":"Am Health Drug Benefits"},{"issue":"2","key":"10.1016\/j.curtheres.2023.100694_bib0034","first-page":"79","article-title":"Comparing healthcare utilization and costs among Medicaid-insured patients with chronic noncancer pain with and without opioid-induced constipation: a retrospective analysis","volume":"10","author":"Olufade","year":"2017","journal-title":"Am Health Drug Benefits"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X23000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X23000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:58:40Z","timestamp":1757897920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X23000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":34,"alternative-id":["S0011393X23000048"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2023.100694","relation":{},"ISSN":["0011-393X"],"issn-type":[{"type":"print","value":"0011-393X"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2023.100694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100694"}}